INS and metabolic syndrome: Indeed, IR, which refers to a complex pathological defect in insulin signalling pathways, resulting in inappropriate cellular response to insulin hormone in insulin-dependent tissues such as skeletal muscle, adipose, and liver tissues, has been proposed as a key underlying pathophysiological pathway in the onset of MetS [7,8,9].